The decrease in PDK-4 expression after Empagliflozin administration was accompanied by a reduction in fatty acid uptake in the liver, suggesting that the protective effect against obesity would actually be the alteration of PDK-4 induced by Empagliflozin [235]. Here, PDK4 is linked to obesity due to melanocortin 4 receptor deficiency.